NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,000 | +16.3% | 106,000 | 0.0% | 0.00% | – |
| Q2 2023 | $135,000 | +1587.5% | 106,000 | +1666.7% | 0.00% | – |
| Q1 2023 | $8,000 | -11.1% | 6,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,000 | 0.0% | 6,000 | -14.3% | 0.00% | – |
| Q3 2022 | $9,000 | +12.5% | 7,000 | +16.7% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 6,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -12.5% | 6,000 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | +60.0% | 6,000 | +50.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Myriad Asset Management Ltd. | 17,500,000 | $29,890,000 | 4.31% |
| SSI INVESTMENT MANAGEMENT LLC | 8,987,000 | $15,319,000 | 1.18% |
| CSS LLC/IL | 14,955,000 | $25,561,000 | 1.09% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,983,000 | $6,799,000 | 0.82% |
| Verition Fund Management LLC | 6,425,000 | $10,968,000 | 0.39% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,495,000 | $16,214,000 | 0.33% |
| MACKAY SHIELDS LLC | 21,609,000 | $36,877,000 | 0.28% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,776,000 | $21,819,000 | 0.25% |
| Calamos Advisors LLC | 24,100,000 | $41,405,000 | 0.23% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,895,000 | $15,184,000 | 0.20% |